Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Recurrence 1Meningeal Carcinomatosis 1

Interventions

Pemetrexed 11Spinal Puncture 5Specimen Handling 4Magnetic Resonance Spectroscopy 4Bevacizumab 4aflutinib 3Radiotherapy, Intensity-Modulated 2tucatinib 1trastuzumab deruxtecan 1sintilimab 1sacituzumab govitecan 1osimertinib 1Trastuzumab 1Temozolomide 1Radiotherapy 1Radiosurgery 1Physical Examination 1Phlebotomy 1Immune Checkpoint Inhibitors 1Drug Therapy 1Deferoxamine 1Craniospinal Irradiation 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Meningeal Carcinomatosis × Deferoxamine × Clear all
NCT05184816 2026-03-27

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
35 enrolled
CNS

Recurrence, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡